Back to Trials
NCT03124303RecruitingAccepts Healthy Volunteers

Interventions for Postoperative Delirium: Biomarker-3

University of Wisconsin, Madison

Start Date

2/13/2017

Completion Date

12/1/2029

Summary

The IPOD-B3 study aims to characterize the relationship between premorbid brain activity and postoperative delirium in patients undergoing major surgery. This is a expansion of the NeuroVISION Bolt-On study, NCT01980511.

Eligibility Criteria

Age Range: 60 years to No maximum

Inclusion Criteria: * Cohort 1: Age ≥65 years * Cohort 2: Age ≥60 years * Anticipated length of hospital stay of at least 2 days after surgery that occurs under general or neuraxial anesthesia * Written Informed Consent for potential participation prior to surgery Exclusion Criteria: * Contraindication to EEG * Unable or unwilling to attend the follow-up appointments * Documented history of dementia * Deemed incapable of providing consent by surgical team * Residing in a nursing home * Undergoing intracranial surgery * Unable to complete neurocognitive testing due to language, vision or hearing impairment * Unable to communicate with the research staff due to language barriers * For optional MRI portion of the study: Contraindication to MRI (e.g., implanted devices not safe for MRI studies, claustrophobia, unable to lie flat or still)

Interventions

PROCEDURE

High Density-Electroencephalogram

PROCEDURE

Magnetic Resonance Imaging

PROCEDURE

Blood specimen collection

DIAGNOSTIC_TEST

Pupillometry

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Delirium

Locations

University of Wisconsin-Madison

Madison, Wisconsin 53792

United States